Is ROIVW or QYLD a better dividend investment in 2026?

ROIVW currently yields 72.73% with a 5% 5-year dividend growth rate. QYLD yields 11.92% with -2.1% growth. The better choice depends on your goal: ROIVW offers higher current income.

What is the dividend yield difference between ROIVW and QYLD?

ROIVW has a forward dividend yield of 72.73% ($2.00/share annually). QYLD yields 11.92% ($2.04/share annually). The yield gap is 60.81 percentage points.

Home › Compare › ROIVW vs QYLD

ROIVW vs QYLD: Dividend Comparison 2026

ROIVW yields 72.73% · QYLD yields 11.92%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 ROIVW wins by $1.17M in total portfolio value

INVESTMENT

TIME HORIZON10 years

ROIVW

● Live price

72.73%

Share price

$2.75

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$1.19M

Annual income

$322,041.74

Full ROIVW calculator →

QYLD

Global X Nasdaq 100 Covered Call ETF

● Live price

11.92%

Share price

$17.15

Annual div

$2.04

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$25.4K

Annual income

$5,659.31

Full QYLD calculator →

Portfolio growth — ROIVW vs QYLD

📍 ROIVW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	ROIVW	QYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, ROIVW + QYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

ROIVW pays

QYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ROIVW

Annual income on $10K today (after 15% tax)

$6,181.82/yr

After 10yr DRIP, annual income (after tax)

$273,735.48/yr

QYLD

Annual income on $10K today (after 15% tax)

$1,013.51/yr

After 10yr DRIP, annual income (after tax)

$4,810.41/yr

At 15% tax rate, ROIVW beats the other by $268,925.07/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ROIVW + QYLD for your $10,000?

ROIVW: 50%QYLD: 50%

100% QYLD50/50100% ROIVW

Portfolio after 10yr

$609.3K

Annual income

$163,850.53/yr

Blended yield

26.89%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ROIVW buys

QYLD buys

No recent congressional trades found for ROIVW or QYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricROIVWQYLD

Forward yield	72.73% ✓	11.92%
Annual dividend / share	$2.00	$2.04 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$1.19M	$25.4K ✓
Annual income after 10y	$322,041.74 ✓	$5,659.31
Total dividends collected	$1.02M	$27.1K ✓
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: ROIVW vs QYLD ($10,000, DRIP)

Year	ROIVW Portfolio	ROIVW Income/yr	QYLD Portfolio	QYLD Income/yr	Gap
1← crossover	$17,973	$7,272.73	$10,352	$1,192.36	+$7.6K → ROIVW
2	$31,447	$12,215.96	$10,830	$1,347.57	+$20.6K → ROIVW
3	$53,624	$19,975.88	$11,460	$1,539.07	+$42.2K → ROIVW
4	$89,213	$31,834.98	$12,275	$1,777.84	+$76.9K → ROIVW
5	$144,956	$49,498.07	$13,323	$2,078.95	+$131.6K → ROIVW
6	$230,267	$75,164.58	$14,667	$2,463.34	+$215.6K → ROIVW
7	$357,976	$111,590.27	$16,396	$2,960.57	+$341.6K → ROIVW
8	$545,165	$162,130.50	$18,631	$3,612.97	+$526.5K → ROIVW
9	$814,083	$230,757.00	$21,548	$4,482.15	+$792.5K → ROIVW
10	$1,193,111	$322,041.74	$25,398	$5,659.31	+$1.17M → ROIVW

ROIVW vs QYLD: Complete Analysis 2026

ROIVW — Stock

Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne, myasthenia gravis, warm autoimmune hemolytic anemia, thyroid eye diseases, sarcoidosis, and staph aureus bacteremia. The company was founded in 2014 and is based in London, the United Kingdom.

Full ROIVW Calculator →

QYLD — ETF

The Global X Nasdaq 100 Covered Call ETF (QYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Nasdaq-100 BuyWrite V2 Index.

Full QYLD Calculator →

📬

Get this ROIVW vs QYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ROIVW vs SCHD ROIVW vs JEPI ROIVW vs O ROIVW vs KO ROIVW vs MAIN ROIVW vs XYLD ROIVW vs JEPQ ROIVW vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.